DocumentClosedother
Enalapril 10mg Arya
South African Health Products Regulatory AuthorityRef: FOR ENALAPRIL 10MG ARYA
Official source
Source domain: sahpra.org.za
Collected on 3 August 2026
Always confirm details on the official source before acting.
What this means
This document is a SAHPRA “Product Recall” notice for Enalapril 10mg Arya, posted on 02 Aug and updated on 29/07/2026 (Version 1). Arya Pharma Pty Ltd is recalling specific batch numbers due to a quality defect: out-of-specification results observed during post-marketing surveillance. Health professionals and distributors are instructed to immediately stop selling/distributing the affected batches, quarantine remaining stock, return it to the supplying warehouse/distributor, and patients should return affected stock to their dispensary. The recall is classified as Class II Type A, with the recall date stated as 29 July 2026, and SAHPRA advises reporting side effects via the Med Safety App.
Facts
Reference
FOR ENALAPRIL 10MG ARYA
Key Takeaways
- Product: Enalapril 10mg Arya
- Company: Arya Pharma Pty Ltd
- Recall classification: Class II Type A
- Recall date: 29 July 2026
- Reason: quality defect/out-of-specification results from post-marketing surveillance
- Instruction: immediately refrain from selling/distributing affected batches
- Instruction: quarantine remaining stock and return to supplying warehouse/distributor
- Instruction: patients return affected stock to dispensary
- Batch numbers listed: GQQ24066, GQQ24064, GQQ24067, GQQ24053 (with expiry dates Sep-2026/Aug-2026 and pack size 28’s)
- SAHPRA contact/side effects: report via Med Safety App
- South African Health Products Regulatory Authority (SAHPRA)
- Arya Pharma Pty Ltd
- Ntokozo Msiza
Dates
Closing Date
29 July 2026